The companies from the Biological Sciences sector are going great in the venture capital market and studies have revealed that this sector has gradually outpaced the other sectors by overcoming even the record lows. The early stage funding for the biological sciences companies had already exceeded $1 billion in the year 2009. This happened in the fourth quarter of the year. The companies in this life sciences industry mainly account for the biotechnology and medical device companies. These are the companies which have captured the maximum share in the overall venture capital market of 2009.

This tremendous growth of the medical device venture capital market even in this economic downturn sure reflects the relative strength of this sector. The life sciences venture capital investments for the year 2009 summed to some $6 billion for around 715 deals. This comprised 34% of the total venture capital dollars investment. In the year 2008, the figure was just 28% for the same. The venture capitalists have thus started eying this sector as a lucrative sector for growth.
According to the venture capital experts, there is always an ever growing need for medical devices, pharmaceuticals and diagnostics and thus this is a great sector for future investments. The early stage companies are at a greater need for venture capital as these do not follow any exit strategy like the later stage companies do. This way, assets can be funneled into the clinics and medical chambers for developing products and devices which will fetch attractive acquisitions in the near future.

In the medical device segment, the sub segment of medical therapeutics has made a historical record by attracting the maximum funding in a quarter. Within this sub segment, the surgical laser companies shot up to 58 %. With this, the surgical equipments and instrumentation also gained in a short percentage.